Recombinant VP1 protein of norovirus GII.4 (Caliciviridae: Norovirus) is capable to induse the production of cross-reacting antibodies
Problems of Virology · 2025
DOI: 10.36233/0507-4088-316 ↗Kurz gefasst
Fachartikel in der Zeitschrift Problems of Virology, 2025. Verfasst von V A Lapin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Academician I.N. Blokhina Nizhny Novgorod Scientific Research Institute of Epidemiology and Microbiology of the Federal Service for Supervision of Co…. Hauptthemen laut MEDLINE: Norovirus, Capsid Proteins, Antibodies, Viral, Caliciviridae Infections. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Norovirus (NoV) is one of the main causes of acute gastroenteritis. Currently, there is no vaccine to prevent norovirus infection. Vaccines under development are based on the capsid protein VP1, which is capable of forming virus-like particles. The aim of the work was to analyze the immunogenic properties of the recombinant VP1 protein of NoV GII.4. Materials and methods. In the blood serum of animals immunized with the recombinant VP1 protein obtained by the authors, titers and avidity of total antibodies and IgM antibodies against NoV VP1 were determined using enzyme immunoassay. The ability of the obtained antibodies to interact with NoV of different genotypes was assessed using immunoelectron microscopy.
Results
The recombinant VP1 protein induced high titer antibody production in animals. Total antibodies against VP1 had a high avidity, reaching 100%, which suggests that they have viral neutralizing activity. IgM antibodies had low avidity. Immunoelectron microscopy showed that IgG antibodies against VP1 protein of genotype GII.4 interact with wild-type NoV of genotype GII.7 and GII.17.
Conclusion
The obtained recombinant protein induces a sufficiently strong immune response with the formation of high avidity polyclonal cross-reacting antibodies, which allows us to consider it as an antigen component of a NoV vaccine candidate.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Academician I.N. Blokhina Nizhny Novgorod Scientific Research Institute of Epidemiology and Microbiology of the Federal Service for Supervision of Consumer Rights Protection and Human Welfare (Rospotrebnadzor).
ORCID-Profile: V A Lapin, D V Novikov, A Y Kashnikov, N V Epifanova, N A Novikova, E V Mokhonova, D A Melentev, M I Tsyganova, D E Zaitsev, V V Novikov
Zitieren
APA
Lapin, V. A., Novikov, D. V., Kashnikov, A. Y., Epifanova, N. V., Novikova, N. A., Mokhonova, E. V., Melentev, D. A., Tsyganova, M. I., Zaitsev, D. E., & Novikov, V. V. (2025). Recombinant VP1 protein of norovirus GII.4 (Caliciviridae: Norovirus) is capable to induse the production of cross-reacting antibodies. Problems of Virology. https://doi.org/10.36233/0507-4088-316
Vancouver
Lapin VA, Novikov DV, Kashnikov AY, Epifanova NV, Novikova NA, Mokhonova EV, et al. Recombinant VP1 protein of norovirus GII.4 (Caliciviridae: Norovirus) is capable to induse the production of cross-reacting antibodies. Problems of Virology. 2025. doi:10.36233/0507-4088-316
BibTeX
@article{Lapin2025,
author = {Lapin, V A and Novikov, D V and Kashnikov, A Y and Epifanova, N V and Novikova, N A and Mokhonova, E V and Melentev, D A and Tsyganova, M I and Zaitsev, D E and Novikov, V V},
title = {Recombinant VP1 protein of norovirus GII.4 (Caliciviridae: Norovirus) is capable to induse the production of cross-reacting antibodies},
journal = {Problems of Virology},
year = {2025},
doi = {10.36233/0507-4088-316}
}
EUVIMED